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Hybrid proteins consisting of N-terminal fragments of increasing length of a Bacillus thuringiensis insectici- 
dal protein (Bt2) fused to neomycin phosphotransferase II (NPTII) were produced in Escherichia coli. The 
minimum fragment required for insect toxicity is comprised of the first 607 amino acids of Bt2. Fusion pro- 
teins not containing this minimum fragment were non-toxic. The NPTII activity of the different non-toxic 
hybrid proteins varied considerably but was not correlated with the length of the Bt2 fragment. Fusion pro- 
teins including the minimum toxic fragment of Bt2 exhibited insecticidal nd NPTII activity comparable 
to that of the individual proteins. This was largely independent of the fusion point within Bt2. Our data 
suggest that the conformation of the Bt2 polypeptide exerts an important influence on the enzymatic activity 
of the fused NPTII protein. The combination of insecticidal activity and a dominant selectable trait into 
one protein offers important advantages for the generation of insect resistant transgenic plants. 
S-Endotoxin; Kanamycin; Hybrid gene; Bifunctional protein; Protein conformation; (Bacillus thuringiensis) 
1. INTRODUCTION 
Artificial fusion proteins have proven to be very 
useful in molecular biology. Fusions with easily 
assayable enzymes like &galactosidase, thymidine 
kinase, alkaline phosphatase and neomycin 
phosphotransferase have been used to study gene 
regulation [1,2], secretion of proteins [3], the 
topology of proteins in membranes [4] and in- 
tracellular transport processes [5]. Also, chimeric 
proteins have been used to analyse the function of 
different domains and their mutual interactions 
[6,7]. Moreover, the design of artificial multifunc- 
tional proteins may have important potential ap- 
plications: e.g. hybrid proteins consisting of a 
peptide hormone and the enzymatically active do- 
main of a toxin have been shown to exhibit a cell- 
specific cytotoxicity [8]. The bioprocessing in- 
dustry might take advantage of artificial bifunc- 
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tional enzymes that perform sequential catalytic 
steps of a biochemical pathway [9]. Another ap- 
plication of fusion proteins is their use to select for 
efficient expression of transformed genes in 
eucaryotic cells. The expression level of foreign 
genes introduced into the eucaryotic genome is in- 
fluenced by their site of insertion [lo]. Cotransfor- 
mation of a selectable marker gene facilitates the 
recognition of cells carrying the desired gene but 
does not ensure its expression, even when both 
genes are closely linked on the same DNA frag- 
ment [l 11. A translational fusion of a selectable 
marker gene to the gene of interest will allow one 
to select for transformants expressing high levels 
of the desired gene through direct selection for the 
phenotype conferred by the marker gene. This 
however requires that the fusion protein exhibits 
the biological activities of both constituent 
proteins. 
Neomycin phosphotransferase II (NPTII) en- 
coded by the neo gene of transposon Tn5 confers 
resistance in bacteria [12] and in eucaryotic cells 
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[ 131 towards aminoglycosides like kanamycin 
(Km), neomycin (Nm) or G418. In addition this 
selectable marker enzyme can retain its activity 
when foreign polypeptides are fused to its N- 
terminus [ 141. 
We constructed fusions between a Bacillus thur- 
ingiensis insect toxin and NPTII and evaluated 
whether they both exhibited insecticidal and 
NPTII activity. S-Endotoxins of B. thuringiensis 
are insecticidal proteins produced as parasporal 
crystalline inclusions during sporulation (review 
[ 151). A typical example is Bt2, a 130 kDa protoxin 
cloned from B. thuringiensis train berliner 1715 
[ 161. Bt2 has potent insecticidal activity against a 
number of lepidopteran insects. It is a protoxin 
which dissolves in the alkaline environment of the 
insect midgut and is proteolytically degraded into 
a 60 kDa toxic core. This toxic fragment was 
localized between amino acids 29 and 607 of the 
protoxin molecule [ 161. 
2.3. Preparation of E. coli extracts for an in vitro 
NPTII assay and toxicity tests 
20 ml LB was inoculated with 0.2 ml of a 
saturated culture and grown at 38°C for approx. 
90 min. The cells were lysed in 1 ml of lysis buffer 
(50 mM Tris-HCl, pH 7.9, 50 mM EDTA, 15% 
sucrose, 0.2 mg/ml phenylmethylsulphonyl fluo- 
ride and 1 mg/ml leupeptin) by a treatment with 
1 mg/ml lysozyme for 30 min at O”C, followed by 
sonication at 0°C for 20 s. The extracts were cen- 
trifuged at 20000 x g for 10 min, the supernatants 
were divided in aliquots and stored at - 70°C until 
use. 
2.4. In vitro NPTII assay 
This paper describes the analysis of fusion pro- 
teins between different N-terminal parts of Bt2 and 
NPTII. Some fusion proteins have both insect tox- 
icity and NPTII activity at levels comparable to 
that of the individual parental proteins. We also 
provide evidence that the NPTII activity of these 
hybrid proteins is largely dependent on the confor- 
mation of the Bt2 moiety. 
This was performed according to Reiss et al. 
[22]. Extracts of 4 x 10’ cells for all clones and 10’ 
cells for K12AHlATrp(pRKM63) were loaded. 
Fragments of the filter corresponding to the intact 
fusion proteins were cut out and the radioactivity 
counted. The amount of NPTII enzyme and fusion 
protein present in the cell extracts was estimated 
from a Western blot with a rabbit anti-NPTII an- 
tiserum, with a dilution series of NPTII as 
standard. 
In a recent study, we have used such bifunc- 
tional fusion proteins to select transformed plants 
expressing B. thuringiensis toxin at levels sufficient 
to protect them from insect damage [17]. 
2.5. Immunological techniques 
Rabbit antisera were raised against Bt2 protein, 
purified from the recombinant E. coli strain 
K514(pGI502) as described [16]. Monoclonal an- 
tibodies 4.8, 5Dll and lOE3 were raised and 
characterized by Hofte et al. (in preparation). 
ELISA assays were done as described 1161. 
2. MATERIALS AND METHODS 2.6. Toxicity assays 
2.1. Bacterial strains, plasmids and growth 
Toxicity tests on 3rd instar larvae of Pieris 
brassicae were performed as described in [16]. 
conditions 
The E. coli strains used were KltiHlATrp, car- 
rying a thermosensitive cI857-repressor [181, and 
K12AHlATrp(pRKM63), which expresses the neo 
gene of Tn5 [ 191. pLBKM25 was constructed as in 
[161. 
3. RESULTS 
3.1. Construction of bt2-neo-fusions and their 
expression in E. coli 
2.2. DNA manipulations 
All molecular cloning procedures were per- 
formed according to Maniatis et al. [20]. DNA se- 
quencing was done according to Maxam and 
Gilbert [2 11. The bt2-neo fusion genes were derived 
from plasmid pLBKm25 (fig.1; [16]). 
A random series of bt2-neo gene-fusions was 
constructed starting from plasmid pLBKm25. This 
plasmid [14] (fig.1) contains the bt2 gene behind 
the A PL promotor. The neo gene, preceded by a 
unique XhoI site is fused at position 3244 of bt2, 
giving rise to the junction sequence indicated in 
fig.lB. pLBKM25 was digested with KpnI, treated 
with Ba131, ligated to XhoI-linkers, digested with 
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6 Select in frame fusions. 
Fig.1. Plasmid pLBKm25 (A) and the strategy used for 
the construction of bt2-neo fusion-genes (B). The 
junction sequence between bt2 and neo in pLBKm25 is 
shown. The numbers indicate the bp position in the Bt2 
sequence. The hatched region in the plasmid 
corresponds to the sequence encoding the active toxin. 
XhoI and self-ligated. E. co/i transformants ex- 
pressing in-frame fusions were selected for Km- 
resistance on 50 pg/ml Km. The fusion positions in 
the bt2 gene were determined using appropriate 
restriction digests, with an accuracy of + 20 bp 
(fig.2). For clones 6, 10 and 11, the exact fusion 
position was determined by DNA sequencing. 
Eleven plasmids containing bt2 segments varying 
between 1430 and 2174 bp were selected for fur- 
ther analysis (fig.2). 
The fusion proteins encoded by these plasmids 
were produced in E. co/i strain K12AHlATrp con- 
taining the temperature sensitive ~I857 repressor. 
Cultures were induced at 38°C to activate the h PL 
promotor. The presence of the hybrid gene prod- 
ucts was determined in the soluble and the pellet 
fraction of cell extracts in Western blots with anti- 
Bt2 and anti-NPTII antibodies (not shown). All 
fusion proteins were of the expected molecular 
mass and for about 50% present in a soluble form. 
We have used the soluble fraction of the E. coli ex- 
tracts in further experiments (fig.3). 
3.2. Insect toxicity of the fusion proteins 
Cell extracts were tested for toxicity against lar- 
vae of P. brassicae (table 1). All clones expressing 
Bt2. fragments smaller than 596 amino acids were 
non-toxic (clones l-6). The bt2-neo-fusions con- 
taining 633 (k 3) or more codons of bt2, encoded 
polypeptides which were as toxic as the intact Bt2 
protein (table 1). This is in agreement with the 
localization of the C-terminus of the minimum 
toxic fragment of Bt2 between codon 599 and 607 
[ 161. Our results indicate that fusing toxic Bt2 
fragments to the NPTII enzyme does not influence 
their insect toxicity. 
3.3. NPTII activity in clones expressing fusion 
proteins 
The minimum inhibitory Km concentration for 
the E. coli clones expressing fusion proteins was 
determined by plating the cultures on media con- 
Table 1 
Toxicity of Bt2-NPTII fusion proteins against Pieris 
brassicae (3rd instar larvae), expressed in percentage 
mortality after 5 days, and reactivity with 3 mabs 
Clone Plasmid Toxicity Reactivity 
(ng/larva) with mabs 
2.50 50 10 4.8 5Dll lOE3 
1 pS20 nd. 4 8 + - _ 
2 pS23 nd. 8 12 + - - 
3 pLBKm865 n.d. 10 8 + - - 
4 ps14 n.d. 12 14 + - - 
5 pS33 n.d. 4 10 + - _ 
6 pS16 n.d. 10 8 + - - 
7 ps13 100 100 56 + + + 
8 pSl1 100 98 60 + + + 
9 PS9 100 87 63 + + + 
10 pLBKm860 100 94 94 + + + 
11 pLBKm23 100 100 65 + + + 
Bt2 (purified) 100 100 80 + + + 
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taining 20,50, 100,200 and 400 pug/ml of Km. The position in the Bt2 sequence. Indeed, it has been 
in vivo resistance level of the different clones shown that Bt2 contains a proteolytic site around 
varied dramatically and was not directly correlated amino acid 610 [ 161, a position which is present in 
to the size of the bt2 segment (fig.2). the toxic fusion proteins. 
The specific NPTII activity of individual pro- 
teins in the E. coli extracts was determined by an 
in situ NPTII assay, after separation of the pro- 
teins on a non-denaturing gel [22]. 
Fig.3b shows that in the E. coli clones NPTII ac- 
tivity was expressed in intact fusion proteins as 
well as in smaller polypeptides. In addition a good 
correlation was observed between the NPTII ac- 
tivity expressed by the different polypeptides pre- 
sent in the E. coli extracts and the in vivo Km 
resistance of the corresponding bacte&. The 5 
clones expressing toxic polypeptides (7- 11) be- 
haved very similar in the in situ assay: the fusion 
proteins exhibited a comparable NPTII activity 
(figs 2,3). In these clones we also observed NPTII 
activity in smaller polypeptides, increasing in size 
from clones 7 to 11. Hence these fragments were 
most likely specific proteolytic degradation 
products generated through cleavage at the same 
The non-toxic clones showed an unexpected pat- 
tern of NPTII activity. In clones 1, 4, 5 and 6, the 
fusion proteins exhibited little or no NPTII activi- 
ty. Accordingly, the Km resistance of clones 1, 4 
and 6 was also very low (fig.2). The high Km 
resistance of clone 5, was solely due to NPTII ac- 
tivity exhibited by a smaller polypeptide. This pro- 
tein could arise through either degradation of the 
fusion protein or more likely, through secondary 
translation initiation within the bt2 sequence. In- 
deed, in clone 5 the neo gene is fused very close to 
an in-frame ATG preceded by a fortuitous 
ribosome binding site (fig.4A). This ATG-codon 
could serve as a secondary translation initiation 
codon. In clone 4, which produced little if any 
smaller polypeptides with NPTII activity, this 
ATG-codon has been removed. A similar observa- 
tion has been reported for hybrid genes derived 
from the EcoRI endonuclease [24]. Clones 3 and 4 
MIC 
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Fig.2. Fusion position in the Bt2 amino acid sequence (+ 3 amino acids), and the minimum inhibiting concentration 
on Km for the E. co/i clones containing the different fusion genes. The hatched bars represent he in situ NPTII activity 
of the intact fusion proteins. Numbers are underlined when the exact position is determined through DNA sequencing. 
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1234567 8 9 10 11 
Fig.3. Western blot with a rabbit anti-Bt2 serum (A) and 
NPTII assay (B) of E. coli clones containing bt2-neo 
fusion-genes with bt2 fragments of decreasing size. The 
numbers are as in table 1. The quantitation of the NPTII 
activity of the intact fusion proteins is shown in fig.2. 
behaved clearly different. Here an important part 
of the NPTII activity was associated with the intact 
fusion proteins. 
In summary, the fusion proteins containing the 
toxic fragment were insecticidal and showed 
A. 
amino acid 550 
.R P I N Q G N F S A T M 
NPTII activity. The non-toxic hybrid proteins of 
clones 1, 4, 5 and 6 showed little or no NPTII ac- 
tivity whereas those of clones 2 and 3 were clearly 
active. 
3.4. The conformation of the Bt2 domain in the 
fusion proteins 
We previously identified 2 monoclonal an- 
tibodies (mabs), 5Dll and lOE3, that recognize 
conformational determinants on Bt2 (Hofte et al., 
unpublished). These determinants disappear upon 
removal of 8 C-terminal amino acids from the 
smallest toxic fragment. However, the C-terminal 
residues are not a part of the epitopes of mabs 
5Dll and lOE3. Also, the epitope of lOE3 con- 
tains, or is closely associated with, amino acids at 
the N-terminus of the toxin. This suggests that 
5Dll and lOE3 recognize epitopes associated with 
a global 3-D structure which is disturbed upon 
removal of the 8 C-terminal residues. To in- 
vestigate if fusion to NPTII influences the confor- 
mation of the Bt2 toxin, we determined in ELISA, 
the reactivity of mabs 5D11, lOE3 and 4.8 with ex- 
tracts of E. coli clones containing the fusion pro- 
teins (table 1). Mab 4.8 recognizes a sequential 
determinant between residue 89 and 163 of Bt2 and 
served as a control. All toxic fusion proteins 
reacted with the 3 mabs whereas extracts contain- 
ing the non-toxic proteins were only recognized by 
S S G S N L Q S G S 
AGA CCT ATT AAT CP(Gi#T TTT TCA GCA ACTDAGT AGT GGG AGT AAT TTA CAG TCC GGA AGC 
:- 4 w 7 5 e 
bp 1640 
0. 
460 470 480 
PLTKSTNLGSGTSVVKGPGFTGGDILRRTS 
-l- -+-_+ 
F R 
TTT AGG 
Fig.4. DNA and deduced amino acid sequence of bt2 around the fusion position to neo. (A) In clones 4 and 5. The 
putative internal secondary translation initiation site and its SD sequence are boxed. (B) In clones 1, 2 and 3. 
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mab 4.8. This suggests that the fusion to NPTII 
did not induce a major disturbance in the global 
3-D structure of the toxin. 
4. DISCUSSION 
This study shows that fusion proteins exhibiting 
both insect toxicity and NPTII activity can be con- 
structed. 
The toxicity of such fusion proteins only 
depends on the presence of the minimum toxic 
fragment of Bt2. This is not unexpected since Bt2 
is a protoxin which is very efficiently processed in- 
to the active toxin by insect midgut proteases. Ap- 
parently, this also occurs for fusion proteins 
containing the toxic fragment, provided that the 
proteolytic site in Bt2 remains accessible. 
The NPTII activity of the toxic fusion proteins 
was not affected by the presence of the Bt2 do- 
main. Moreover, the reactivity of the toxic fusion 
proteins with mabs 5Dll and lOE3 suggested that 
the 3-D structure of the Bt2 toxin was not dis- 
turbed by the fusion to NPTII. Hence, we assume 
that in the toxic hybrid proteins, both the Bt2 and 
the NPTII domains were independently folded, 
which is in accordance with the high NPTII activi- 
ty of these fusion proteins. 
The situation for the non-toxic fusions was very 
different. The intact fusion proteins of clones 1, 4, 
5 and 6 showed little or no NPTII activity, whereas 
those of clones 2 and 3 were clearly active. 
We presume that in clones 1, 4, 5 and 6 a distur- 
bance of the tertiary structure of the Bt2 moiety 
also imposed a change in the folding of the NPTII 
domain with a consequent loss of its activity. This 
idea was substantiated by previous experiments 
with monoclonal antibodies which demonstrate 
that the removal of 8 amino acids from the C- 
terminus of the minimum toxic fragment induces a 
dramatic conformational change through the 
whole molecule (Hofte et al., unpublished). The 
NPTII activity of the non-toxic fusion proteins of 
clones 2 and 3 could indicate that here the NPTII 
enzyme is fused at a large loop region in the toxin 
molecule, which is flexible enough to allow an in- 
dependent folding of the NPTII domain. In clones 
2 and 3 the fusion position to NPTII indeed is 
located in a region rich in Gly (fig.4B) allowing the 
flexibility typical for loop structures. 
Reiss et al. [14] showed that the addition of long 
protein fragments to the N-terminus of NPTII 
almost invariably interfered with its activity. In 
these cases the presence of active proteolytic 
fragments accounted for the observed NPTII ac- 
tivity and Km resistance. Our data clearly show 
that even very long protein segments (up to 700 
amino acids) can be fused to the N-terminus of 
NPTII without disturbing its activity, on condition 
that these polypeptides fold into an independent 
structure which does not interfere with the NPTII 
enzyme. 
The applicability of such proteins was ex- 
emplified in a recent study in which the hybrid 
genes of clones 10 and 11 were expressed in tobac- 
co plants. The selection on high levels of Km in- 
deed delivered transformed plant cells expressing 
sufficient amounts of fusion protein to confer 
resistance to lepidopteran larvae [ 171. 
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